Nicolai Tangen - AKO Capital 13F Activity & Position Changes (Q2 2018)

As of Jun 30, 2018, the AKO Capital portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on May 15, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q2 2018, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q2 2018
ABEV
Ambev S.A.
Buy
+613,699
Q2 2018
ANSS
ANSYS, Inc.
Buy
+25,843
Q2 2018
CL
Colgate-Palmolive Company
Buy
+62,927
Q2 2018
CME
CME Group Inc.
Buy
+32,369
Q2 2018
CTSH
Cognizant Technology Solutions
Buy
+78,393
Q2 2018
EL
Estee Lauder Companies, Inc. (T
Buy
+89,364
Q2 2018
EW
Edwards Lifesciences Corporatio
Buy - Position Entry
+243,336
Q2 2018
FICO
Fair Isaac Corporation
Buy
+52,052
Q2 2018
G0176J109
Allegion
Buy
+107,892
Q2 2018
GOOG
Alphabet Inc.
Buy
+8,186
Q2 2018
GRFS
Grifols, S.A.
Sell
-889,997
Q2 2018
MAR
Marriott International
Buy
+45,998
Q2 2018
MCO
Moody's Corporation
Sell
-26,327
Q2 2018
NKE
Nike, Inc.
Buy
+374,448
Q2 2018
RACE
Ferrari
Sell
-304,338
Q2 2018
USB
U.S. Bancorp
Sell
-78,839
Q2 2018
V
Visa Inc.
Buy
+61,761